# 68001-313-56 · Azacitidine Injection · Teva Pharmaceuticals USA, Inc. — FDA drug shortage duration tracker

For 68001-313-56 · Azacitidine Injection · Teva Pharmaceuticals USA, Inc., package ndc is 68001-313-56; generic name is Azacitidine Injection; manufacturer is Teva Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

- **Package NDC:** 68001-313-56 _(verified: appears in the quote below)_
- **Generic name:** Azacitidine Injection _(verified: appears in the quote below)_
- **Manufacturer:** Teva Pharmaceuticals USA, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated recovery: TBD _(verified: appears in the quote below)_
- **Initial posting date:** 12/22/2020 _(verified: appears in the quote below)_
- **Last update date:** 08/17/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 2079 _(our reading, not quoted from the source)_
- **Reason for shortage:** Other _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "12/22/2020", "package_ndc": "68001-313-56", "generic_name": "Azacitidine Injection", "contact_info": "800-545-8800", "availability": "Unavailable", "related_info": "Estimated recovery: TBD"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Status

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Last update date

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Reason for shortage

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Dosage form

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Therapeutic category

> "update_date": "08/17/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).